DEBORAH DAVIDSON: Open Payments
NPI 1063813178 · TIPTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 26 payments from 8 companies in 2025. Trend: 2023 $509 · 2024 $342 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $210 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $151 |
| Axsome Therapeutics, Inc. | 1 | $118 |
| Supernus Pharmaceuticals, Inc. | 1 | $61 |
| Lundbeck LLC | 2 | $35 |
| Corium, LLC | 4 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: ABILIFY MAINTENA, CAPLYTA, Auvelity, REXULTI, Qelbree, Azstarys, COBENFY, AUSTEDO XR.
Industry payments across IN — which companies pay providers there.
